Association between rheumatoid arthritis-interstitial lung disease and lung cancer: a two -sample Mendelian randomization study with East Asian genetic instruments

Clicks: 3
ID: 325464
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #30 of 36 articles by views in modern rheumatology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Objectives Epidemiological studies consistently report an increased risk of lung cancer among rheumatoid arthritis patients. Proposed risk factors include male sex, smoking, and rheumatoid arthritis-associated interstitial lung disease. However, whether a direct genetic causal link exists between rheumatoid arthritis-associated interstitial lung disease and lung cancer remains unexplored. We used Mendelian randomization with East Asian genetic instruments to evaluate this relationship. Methods We conducted a two-sample Mendelian randomization in which genetic instruments for rheumatoid arthritis-associated interstitial lung disease were derived from an East Asian GWAS (358 RA-ILD cases, 4 550 RA controls), and lung cancer associations were obtained from a cross-ancestry GWAS meta-analysis (20 378 cases, 18 696 controls). Causal effects were estimated using inverse-variance weighted, Mendelian randomization-Egger, and weighted median methods. Results Ten single nucleotide polymorphisms were identified as genetic instruments. Inverse-variance weighted analysis revealed no significant causal association between genetically predicted rheumatoid arthritis-associated interstitial lung disease and lung cancer (odds ratio = 1.00; 95% confidence interval: 0.99–1.01; p-value = 0.78). Sensitivity analyses showed no horizontal pleiotropy or heterogeneity. Conclusions Our findings suggest that the severe lung complications of rheumatic arthritis do not inherently share a direct, genetically driven pathway with malignancy. The observed clinical risk may be explained by shared environmental factors, such as smoking, or chronic immune dysregulation, rather than inherent genetic pleiotropy, although further investigation is needed to clarify these mechanisms.
Reference Key
openalex_W7203820230 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Chueh-Hsuan Hsu, Shuo‐Chueh Chen, Yung‐Luen Yu
Journal modern rheumatology
Year 2026
DOI
10.1093/mr/roag068
URL
https://doi.org/10.1093/mr/roag068
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.